Substance Use Disorders: A Comprehensive Review and Update 2027 is an immersive, clinically focused in-person conference held from February 15 to February 17, 2027, at Disney’s Grand Floridian Resort & Spa. Organized by the Massachusetts General Hospital Psychiatry Academy, the conference addresses substance use disorders across all care environments, emphasizing practical, actionable strategies grounded in current research to help healthcare professionals stay up to date and clinically effective.
The educational program covers the full spectrum of addiction care across eleven modules. Topics include the neurobiology and genetics of addiction, adolescent substance use disorders, ADHD and substance use, athletic considerations, psychedelics, and benzodiazepines. In-depth clinical modules dedicated to opioids examine buprenorphine, long-acting injectable formulations, intramuscular naltrexone, and methadone, alongside pain management and addiction during pregnancy. Additional sessions explore cannabis, evidence-based behavioral therapies including motivational interviewing, cognitive behavioral therapy (CBT), and dialectical behavior therapy (DBT), as well as digital and gambling addictions. Attendees will also examine comorbidity involving trauma and sex trafficking, cocaine, methamphetamine, nicotine, GLP-1 receptor agonists, stigma reduction, recovery communities, and alcohol withdrawal management and neurotherapeutics.
The target audience encompasses general and family physicians, psychiatrists, nurse practitioners, nurses, psychologists, and social workers. Participants can earn 15.25 AMA PRA Category 1 Credit™, 15.25 Nursing Contact Hours, 15.25 Social Workers credit hours, 15.25 Participation credit, 15.25 Psychologists CE Credit, and 15.25 Interprofessional Continuing Education (IPCE) credits.
Registration tiers for MDs and doctoral-level professionals are $975.00 for Super Early Bird (before August 31, 2026), $1,035.00 for Early Bird (before November 30, 2026), and $1,139.00 for Regular Registration (after December 1, 2026). For other professionals or trainees, rates are $875.00 for Super Early Bird, $931.00 for Early Bird, and $1,035.00 for Regular Registration. Attendees receive free access to a digital e-syllabus for 30 days post-conference, with an optional printed syllabus available for on-site pickup at $85.00.
Fees (as published by the organiser): MDs/Doctoral-Level Professionals: Super Early Bird Registration (before August 31, 2026): $975.00, Early Bird Registration (before November 30, 2026): $1,035.00, Regular Registration (after December 1, 2026): $1,139.00. Other Professionals or Trainees: Super Early Bird Registration (before August 31, 2026): $875.00, Early Bird Registration (before November 30, 2026): $931.00, Regular Registration (after December 1, 2026): $1,035.00. Optional Printed Syllabus: $85.00.
Credits: 15.25 AMA PRA Category 1 Credit™ 15.25 Nursing Contact Hours 15.25 Social Workers 15.25 Participation 15.25 Psychologists CE Credit
Faculty / directors: Timothy E. Wilens, MD, Chief, Division of Child and Adolescent Psychiatry; (Co) Director, Center for Addiction Medicine; Professor of Psychiatry, Massachusetts General Hospital; Harvard Medical School; Laura G. Kehoe, MD, MPH, FASAM, Medical Director, Health Care Resources Opioid Treatment Program; Assistant Professor, Massachusetts General Hospital; Harvard Medical School; John F. Kelly, PhD, ABPP, Elizabeth R. Spallin Professor of Psychiatry; Director, MGH Recovery Research Institute, Harvard Medical School; Massachusetts General Hospital; Robert R. Althoff, MD, PhD, Professor of Psychiatry, Pediatrics, & Psychological Science; Chair, Department of Psychiatry, Larner College of Medicine at the University of Vermont; Jessica Gray, MD, Medical Director, MGH HOPE Clinic; Associate Fellowship Director, MGH Addiction Medicine Fellowship, Massachusetts General Hospital; James McKowen, MD, PhD, Licensed Psychologist; Assistant Professor of Psychology; Clinical Director, ARMS, Harvard Medical School; Massachusetts General Hospital; Abigail M. Judge, PhD, Co-Founder, Boston HEAT; Instructor, Massachusetts General Hospital; Harvard Medical School; Megan Hudson, MSN, PMHNP-BC, Clinical Nurse Educator; David Eddie, PhD, ABPP, Associate Director of Clinical Translational Recovery Science, Massachusetts General Hospital; Vinod Rao, MD, PhD, Addiction Psychiatrist and Medical Director - West End Clinic, Massachusetts General Hospital